IRCT20200506047323N3招募中3 期
Evaluation of the efficacy and safety of Favipiravir and Interferon beta compared to Lopinavir/Ritonavir and Interferon beta in patients with COVID-19
Bandare-abbas University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age =18 years
- •Positive polymerase chain reaction (PCR) test for COVID-19
- •Primary clinical symptoms
- •Hospitalized
- •Signing informed consent and willingness of study participant to accept randomization to any assigned treatment arm
排除标准
- •Underlying diseases, including chronic hepatitis, cirrhosis, cholestatic liver diseases, cholecystitis, and peptic ulcers
- •Acute and chronic renal failure
- •Peptic ulcers
- •History of allergy to studied drugs
- •Pregnancy and breastfeeding
研究者
相似试验
招募中
3 期
The evaluation of efficacy of Favipiravir in patients with mild to moderate COVID-19IRCT20201005048936N1Dr. Abidi pharmacutical Co.126
招募中
3 期
Evaluation the effects of Favipiravir in COVID-19 patientsCOVID-19 pneumonia.COVID-19, virus identifiedU07.1IRCT20151227025726N14Shahid Beheshti University of Medical Sciences84
招募中
2 期
Effectiveness of favipiravir in comparison with Tenofovir Alafenamid in patients with COVID-19COVID-19.COVID-19U07.1IRCT20150808023559N23Ardabil University of Medical Sciences100
已完成
不适用
Investigation on the efficacy and safety of favipiravir in patients who are infected or strongly suspected of being infected with Ebola virusEbola virus diseaseJPRN-UMIN000016101ational Center for Global Health and Medicine5
招募中
3 期
Evaluation of the efficiency and safety of favipiravir + hydroxychloroquine drug regimen in comparison with hydroxychloroquine in hospitalized patients with covid-19IRCT20200428047228N1Quality Improvement of Intensive Care Research Center- Shahid Beheshti University50